As per Intent Market Research, the Cord Blood Banking Market was valued at USD 1.0 billion in 2024-e and will surpass USD 1.9 billion by 2030; growing at a CAGR of 11.3% during 2025 - 2030.
The cord blood banking market is witnessing significant growth due to the increasing awareness of the therapeutic potential of stem cells, advancements in regenerative medicine, and the rising prevalence of blood-related disorders. Cord blood, rich in hematopoietic stem cells (HSCs), is widely used in treating various conditions, including cancer, immune deficiencies, and metabolic disorders. The growing investment in stem cell research and government initiatives supporting cord blood banking further contribute to market expansion.
Additionally, technological advancements in cord blood processing, cryopreservation techniques, and improved transplantation success rates are fueling market demand. The expansion of hybrid banking models, offering both private and public storage options, is also playing a pivotal role in market growth.
Public Cord Blood Banks Drive Market Growth Due to Increased Donations
Public cord blood banks hold a significant share of the market, primarily due to the rising awareness of voluntary donations and the role of public banking in making stem cell transplants more accessible. These banks collect and store donated cord blood, which can be used for unrelated transplants and research purposes.
Private cord blood banks are also experiencing steady growth, driven by the increasing trend of parents preserving their newborn’s cord blood for potential future medical use. Hybrid cord blood banks, offering both public and private storage options, are gaining traction due to their flexibility and dual benefits.
.JPG)
Storage & Preservation Services Lead Due to Long-Term Cryogenic Storage Needs
Among service types, storage and preservation account for the largest market share, as long-term cryogenic storage is critical for maintaining the viability of stem cells. Advanced freezing and thawing techniques, coupled with improvements in liquid nitrogen storage, ensure optimal preservation conditions.
Processing and testing services are also integral to the market, as they ensure the quality and usability of collected cord blood samples. Innovations in automated processing systems and quality control measures are enhancing efficiency and standardization in the industry.
Cancer Treatment Remains the Leading Application Segment
Cancer treatment dominates the market, with cord blood transplants increasingly used in leukemia, lymphoma, and other hematological malignancies. The effectiveness of cord blood stem cells in restoring bone marrow and boosting immune function post-chemotherapy is a key driver in this segment.
Blood disorders, including sickle cell anemia and thalassemia, also represent a major application area. Advances in gene therapy and personalized medicine are expanding the scope of cord blood applications, increasing its clinical and therapeutic relevance.
Hospitals & Specialty Clinics Are the Primary End Users
Hospitals and specialty clinics constitute the largest end-user segment, as they are the primary centers for cord blood collection, storage coordination, and transplantation procedures. The growing adoption of stem cell therapies in clinical settings is driving demand for cord blood banking services in hospitals.
Research institutes are also key contributors to market growth, given the increasing focus on stem cell research, regenerative medicine, and clinical trials exploring new applications for cord blood-derived stem cells.
North America Leads, While Asia-Pacific Sees Rapid Growth
North America dominates the cord blood banking market due to well-established healthcare infrastructure, favorable regulatory policies, and high awareness regarding stem cell therapy. The presence of leading private and public cord blood banks, along with robust funding for regenerative medicine, supports market expansion.
Asia-Pacific is witnessing the fastest growth, driven by increasing birth rates, rising healthcare investments, and growing government support for stem cell banking initiatives. Countries such as China, India, and Japan are experiencing a surge in demand for both private and public cord blood banking services.
.JPG)
Competitive Landscape and Key Players
The cord blood banking market is highly competitive, with major players such as Cord Blood Registry (CBR), Cryo-Cell International, Viacord, China Cord Blood Corporation, and Global Cord Blood Corporation leading the industry. These companies focus on expanding their storage capacities, improving processing technologies, and increasing awareness through educational campaigns.
Strategic collaborations between healthcare institutions and research organizations, along with technological advancements in automated storage and processing systems, are shaping the future of the market. As stem cell applications continue to expand, the cord blood banking industry is poised for sustained growth.
List of Leading Companies:
- CBR (Cord Blood Registry)
- ViaCord
- Cryo-Cell International
- Global Cord Blood Corporation
- LifeCell International
- StemCyte
- China Cord Blood Corporation
- Americord Registry
- Smart Cells International Ltd.
- Vita34 AG
- FamiCord Group
- HealthBanks Biotech USA
- Cryo-Save AG
- CordVida
- Biovault Family
Recent Developments:
- In January 2025, CBR announced an expanded storage facility to enhance stem cell preservation capabilities.
- In December 2024, ViaCord introduced an advanced testing service for cord blood viability before transplantation.
- In November 2024, Cryo-Cell International partnered with a leading research institute to develop new stem cell therapies.
- In October 2024, Global Cord Blood Corporation launched a new public banking initiative to increase donor participation.
- In September 2024, LifeCell International received regulatory approval for a next-generation cord blood processing technology.
Report Scope:
|
Report Features |
Description |
|
Market Size (2024-e) |
USD 1.0 billion |
|
Forecasted Value (2030) |
USD 1.9 billion |
|
CAGR (2025 – 2030) |
11.3% |
|
Base Year for Estimation |
2024-e |
|
Historic Year |
2023 |
|
Forecast Period |
2025 – 2030 |
|
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
|
Segments Covered |
Cord Blood Banking Market By Type (Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks), By Service Type (Collection & Transportation, Processing, Storage & Preservation, Testing), By Application (Cancer Treatment, Blood Disorders, Immune Disorders, Metabolic Disorders), By End User (Hospitals & Specialty Clinics, Research Institutes) |
|
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
|
Major Companies |
CBR (Cord Blood Registry), ViaCord, Cryo-Cell International, Global Cord Blood Corporation, LifeCell International, StemCyte, China Cord Blood Corporation, Americord Registry, Smart Cells International Ltd., Vita34 AG, FamiCord Group, HealthBanks Biotech USA, Cryo-Save AG, CordVida, Biovault Family |
|
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
Frequently Asked Questions
The Cord Blood Banking Market was valued at USD 1.0 billion in 2024-e and is expected to grow at a CAGR of over 11.3% from 2025 to 2030.
Increasing awareness of stem cell therapy, advancements in regenerative medicine, and rising demand for hematopoietic stem cell transplants are key drivers.
Public banks store donated cord blood for use by any matching recipient, while private banks store for exclusive use by the donor’s family.
Cord blood contains hematopoietic stem cells that can be used in treating various blood disorders, cancers, and immune system diseases.
Cord blood stem cells are used to treat leukemia, lymphoma, sickle cell anemia, and certain metabolic and immune disorders.
|
1. Introduction |
|
1.1. Market Definition |
|
1.2. Scope of the Study |
|
1.3. Research Assumptions |
|
1.4. Study Limitations |
|
2. Research Methodology |
|
2.1. Research Approach |
|
2.1.1. Top-Down Method |
|
2.1.2. Bottom-Up Method |
|
2.1.3. Factor Impact Analysis |
|
2.2. Insights & Data Collection Process |
|
2.2.1. Secondary Research |
|
2.2.2. Primary Research |
|
2.3. Data Mining Process |
|
2.3.1. Data Analysis |
|
2.3.2. Data Validation and Revalidation |
|
2.3.3. Data Triangulation |
|
3. Executive Summary |
|
3.1. Major Markets & Segments |
|
3.2. Highest Growing Regions and Respective Countries |
|
3.3. Impact of Growth Drivers & Inhibitors |
|
3.4. Regulatory Overview by Country |
|
4. Cord Blood Banking Market, by Type (Market Size & Forecast: USD Million, 2023 – 2030) |
|
4.1. Public Cord Blood Banks |
|
4.2. Private Cord Blood Banks |
|
4.3. Hybrid Cord Blood Banks |
|
4.4. Others |
|
5. Cord Blood Banking Market, by Service Type (Market Size & Forecast: USD Million, 2023 – 2030) |
|
5.1. Collection & Transportation |
|
5.2. Processing |
|
5.3. Storage & Preservation |
|
5.4. Testing |
|
5.5. Others |
|
6. Cord Blood Banking Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
|
6.1. Cancer Treatment |
|
6.2. Blood Disorders |
|
6.3. Immune Disorders |
|
6.4. Metabolic Disorders |
|
6.5. Others |
|
7. Cord Blood Banking Market, by End User (Market Size & Forecast: USD Million, 2023 – 2030) |
|
7.1. Hospitals & Specialty Clinics |
|
7.2. Research Institutes |
|
7.3. Others |
|
8. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
|
8.1. Regional Overview |
|
8.2. North America |
|
8.2.1. Regional Trends & Growth Drivers |
|
8.2.2. Barriers & Challenges |
|
8.2.3. Opportunities |
|
8.2.4. Factor Impact Analysis |
|
8.2.5. Technology Trends |
|
8.2.6. North America Cord Blood Banking Market, by Type |
|
8.2.7. North America Cord Blood Banking Market, by Service Type |
|
8.2.8. North America Cord Blood Banking Market, by Application |
|
8.2.9. North America Cord Blood Banking Market, by End User |
|
8.2.10. By Country |
|
8.2.10.1. US |
|
8.2.10.1.1. US Cord Blood Banking Market, by Type |
|
8.2.10.1.2. US Cord Blood Banking Market, by Service Type |
|
8.2.10.1.3. US Cord Blood Banking Market, by Application |
|
8.2.10.1.4. US Cord Blood Banking Market, by End User |
|
8.2.10.2. Canada |
|
8.2.10.3. Mexico |
|
*Similar segmentation will be provided for each region and country |
|
8.3. Europe |
|
8.4. Asia-Pacific |
|
8.5. Latin America |
|
8.6. Middle East & Africa |
|
9. Competitive Landscape |
|
9.1. Overview of the Key Players |
|
9.2. Competitive Ecosystem |
|
9.2.1. Level of Fragmentation |
|
9.2.2. Market Consolidation |
|
9.2.3. Product Innovation |
|
9.3. Company Share Analysis |
|
9.4. Company Benchmarking Matrix |
|
9.4.1. Strategic Overview |
|
9.4.2. Product Innovations |
|
9.5. Start-up Ecosystem |
|
9.6. Strategic Competitive Insights/ Customer Imperatives |
|
9.7. ESG Matrix/ Sustainability Matrix |
|
9.8. Manufacturing Network |
|
9.8.1. Locations |
|
9.8.2. Supply Chain and Logistics |
|
9.8.3. Product Flexibility/Customization |
|
9.8.4. Digital Transformation and Connectivity |
|
9.8.5. Environmental and Regulatory Compliance |
|
9.9. Technology Readiness Level Matrix |
|
9.10. Technology Maturity Curve |
|
9.11. Buying Criteria |
|
10. Company Profiles |
|
10.1. CBR (Cord Blood Registry) |
|
10.1.1. Company Overview |
|
10.1.2. Company Financials |
|
10.1.3. Product/Service Portfolio |
|
10.1.4. Recent Developments |
|
10.1.5. IMR Analysis |
|
*Similar information will be provided for other companies |
|
10.2. ViaCord |
|
10.3. Cryo-Cell International |
|
10.4. Global Cord Blood Corporation |
|
10.5. LifeCell International |
|
10.6. StemCyte |
|
10.7. China Cord Blood Corporation |
|
10.8. Americord Registry |
|
10.9. Smart Cells International Ltd. |
|
10.10. Vita34 AG |
|
10.11. FamiCord Group |
|
10.12. HealthBanks Biotech USA |
|
10.13. Cryo-Save AG |
|
10.14. CordVida |
|
10.15. Biovault Family |
|
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Cord Blood Banking Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Cord Blood Banking Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
.png)
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the Automated Breast Ultrasound Systems ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Cord Blood Banking Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
.jpg)
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.